Endocrine oncology

A Qualitative Thematic Analysis Exploring Chinese Young Adults’ Experiences in Decision Making on the Management of Low-Risk Papillary Thyroid Cancer

ThyroidPublished Qualitative study

Authors' conclusion

These results highlight the necessity of adopting flexible strategies when supporting collaborative treatment decision making in the context of the doctor-patient interaction for low-risk PTC.

Study context

Population
Chinese young adults (18–38 years) diagnosed with low-risk papillary thyroid cancer (PTC), March 2023–May 2024; 22 of 24 with tumour ≤1 cm, largest 1.47 cm4 men · 20 women
Participants
24 adults
Outcome
Shared decision-making (SDM) experiences of young patients with low-risk PTC
Methodological detailsqualitative descriptive design, semistructured interviews, reflexive thematic analysis
  • Qualitative descriptive design
  • Semistructured interviews
  • Reflexive thematic analysis

Main finding

As reported in the abstract

  • Four themes: challenges in information sharing; reasons for information seeking; factors influencing decision making; self-positioning in treatment decision making
  • Three self-positions: dependent ("paternalistic"), collaborative ("sharing"), autonomous (increased personal responsibility for health and engagement in decision making)
  • Main information-sharing challenges: limited treatment options offered, overuse of medical terminology, clinician–patient communication gaps
  • Information needs persisting after consultations led to active information seeking
  • Key variables potentially affecting decision making: future personal considerations, language used to discuss cancer, negative emotions

Original publication

A Qualitative Thematic Analysis Exploring Chinese Young Adults’ Experiences in Decision Making on the Management of Low-Risk Papillary Thyroid Cancer. Thyroid. Published 17 October 2024. doi:10.1089/thy.2024.0210

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.